Juan Li
4PUBLICATIONS
46CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Jan 29, 2025
First-Line Mobocertinib Versus Platinum-Based Chemotherapy in Patients With <i>EGFR</i> Exon 20 Insertion-Positive Metastatic Non-Small Cell Lung Cancer in the Phase III EXCLAIM-2 Trial.Pasi A Jänne, Bin-Chao Wang, Byoung Chul Cho
|Jun 10, 2024
Subcutaneous Versus Intravenous Amivantamab, Both in Combination With Lazertinib, in Refractory Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: Primary Results From the Phase III PALOMA-3 Study.Natasha B Leighl, Hiroaki Akamatsu, Sun Min Lim
|Feb 28, 2023
Real-world clinical analysis in 190 advanced NSCLC patients with uncommon EGFR mutations: A multi-center study.Yi Qin, Yaling Long, Yuan Tang
|Nov 08, 2022
Anlotinib plus chemotherapy for T790M-negative EGFR-mutant non-sqNSCLC resistant to TKIs: A multicenter phase 1b/2 trial.Juan Li, Yuke Tian, Min Zheng
Pageof 1
Frequent Collaborators
2 joint publications
Danny Nguyen
1 joint publications
You Lu
1 joint publications
Meijuan Huang
1 joint publications
Natasha B Leighl
1 joint publications
Hiroaki Akamatsu
1 joint publications
Sun Min Lim
1 joint publications
Ying Cheng
1 joint publications
Anna R Minchom
1 joint publications
Melina E Marmarelis
1 joint publications
Rachel E Sanborn
